Clinical Trials
20 trialsNCT04105270 2025-09-11
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
Masonic Cancer Center, University of Minnesota
Phase 2 Recruiting
NCT05266846 2024-05-30
BEYOND
Hunan Province Tumor Hospital
Phase 2 Recruiting
NCT02980991 2023-07-20
Pemetrexed and Platinum Use in the Neoadjuvant Setting for Resectable Stage II and IIIA Lung Adenocarcinoma (ECTOP-1002)
Fudan University
Phase 2 Completed
NCT03380468 2023-07-20
ECTOP-1004
Fudan University
Phase 2/3 Unknown
NCT02120807 2023-01-26
Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT01059188 2022-03-11
Neo-adjuvant Treatment in Non-Small Cell Lung Cancer (NSCLC)
Swiss Cancer Institute
Phase 2 Completed
NCT01958372 2020-11-23
Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer
Barbara Ann Karmanos Cancer Institute
Phase 1 Completed
NCT03544814 2019-10-15
EGFR-TKI Combined With Concurrent or Sequential Chemotherapy for Patients of Gradual Progression
Shanghai Chest Hospital
Phase 2 Completed
NCT00003231 2019-05-15
Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer
Swiss Cancer Institute
Phase 2 Completed
NCT00354549 2019-05-15
Bevacizumab and Erlotinib Followed by Cisplatin or Carboplatin and Gemcitabine in Treating Patients With Newly Diagnosed or Recurrent Stage IIIB or Stage IV NSCLC
Swiss Cancer Institute
Phase 2 Completed
NCT01116219 2019-05-15
Bevacizumab, Pemetrexed Disodium, and Cisplatin or Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer. A Multicenter Phase II Trial Including Biopsy at Progression (BIO-PRO Trial).
Swiss Cancer Institute
Phase 2 Completed
NCT00003202 2018-08-10
Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
Wake Forest University Health Sciences
Phase 1/2 Completed
NCT01557959 2018-06-29
Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Wake Forest University Health Sciences
Phase 2 Completed
NCT03351842 2017-12-19
Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20%
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Recruiting
NCT00863512 2017-03-27
Chemotherapy or Observation in Treating Patients With Early Stage Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Terminated
NCT00005850 2016-07-04
Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT00077311 2016-06-30
Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT01578668 2015-01-26
Erlotinib Plus Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases
Guangzhou Medical University
Phase 2 Completed
NCT00002823 2013-03-28
Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris
Phase 3 Completed
NCT00217698 2012-06-05
Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Swiss Cancer Institute
Phase 2 Completed